Gilead Sciences Inc (GILD)

GILD (NASDAQ:Drugs) EQUITY
$86.55
pos +0.00
+0.00%
Today's Range: 86.32 - 87.44 | GILD Avg Daily Volume: 9,480,000
Last Update: 07/22/16 - 4:00 PM EDT
Volume: 0
YTD Performance: -14.47%
Open: $0.00
Previous Close: $87.24
52 Week Range: $77.92 - $120.37
Oustanding Shares: 1,331,821,506
Market Cap: 116,188,108,183
6-Month Chart
TheStreet Ratings Grade for GILD
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 8 9 9
Moderate Buy 2 2 2 2
Hold 7 7 7 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.94 1.94 1.89 1.82
Latest Dividend: 0.47
Latest Dividend Yield: 2.16%
Dividend Ex-Date: 06/14/16
Price Earnings Ratio: 7.27
Price Earnings Comparisons:
GILD Sector Avg. S&P 500
7.27 7.30 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-15.09% -26.30% 44.95%
GROWTH 12 Mo 3 Yr CAGR
Revenue 31.10 2.40 0.49
Net Income 50.10 6.00 0.90
EPS 62.00 6.20 0.92
Earnings for GILD:
EBITDA 23.29B
Revenue 32.64B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $3.02 $2.96 $11.84 $12.84
Number of Analysts 2 2 2 2
High Estimate $3.25 $3.16 $12.57 $14.45
Low Estimate $2.79 $2.76 $11.10 $11.23
Prior Year $3.10 $3.19 $12.45 $11.84
Growth Rate (Year over Year) -2.58% -7.21% -4.94% 8.49%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
By

Bret Jensen

 | Jul 21, 2016 | 11:00 AM EDT
Watch these names as stability returns to the sector.
By

Bret Jensen

 | Jul 18, 2016 | 11:00 AM EDT
The biotech juggernaut still has a lot going for it, especially at these levels.
By

Bruce Kamich

 | Jul 12, 2016 | 12:08 PM EDT
Each bounce in the stock has been followed by a move to lower lows.
By

Bret Jensen

 | Jul 12, 2016 | 11:00 AM EDT
A look at who will be up and who will down this earnings season.
By

Jim Cramer

 | Jul 11, 2016 | 10:40 AM EDT
They need to do something that makes them stand out as stocks you want to own, not avoid.
By

Paul Price

 | Jul 11, 2016 | 10:00 AM EDT
Biotechs now offer some great valuations, and BIIB is prime example.
By

Doug Kass

 | Jul 1, 2016 | 4:56 PM EDT
The U.S. dollar weakened. The price of crude oil rose by 83 cents to $49.15. Gold roared ahead, up $25 to $1,345 as it breakouts from the $1,300 level. Agricultural commodities got schmeissed across the board: wheat -16, corn -4, soybean -16 and oats -7. Bonds continued to ramp. iShares 20+ Year Treasury Bond ETF (TLT) was up $1.68. The yield on the 10-year U.S. note dropped by four basis points to 1.46% after hitting 1.40% early in the morning. The long bond yield declined by seven basis points to a 2.24% yield. The 2s/10s spread declined to a new record low of 85 basis points. Not good for financials that borrow short and lend longer and that have an asset-sensitive balance sheet. Municipal bonds were down small but closed-end funds traded somewhat higher. High-yield bonds were mixed. Blackstone/GSO Strategic Credit Fund (BGB) was up a dime and back to $14.50 in the search for yield. Banks disappointed for the second day in a row, as I suggested in my Sell Banks post yesterday morning. http://realmoneypro.thestreet.com/dougs-daily-diary?published[value][date]=2016-06-30#why-im-not-bank-20160630 All major money center banks were lower today. After the close Warren Buffett filed for permission to go over 10% of Wells Fargo's (WFC) ownership, though he currently doesn't have an intention to do so. He is averaging down! Brokerage stocks also were lower, but marginally so. Insurance stocks also stunk after a feeble rally from large declines in the last week. I remain short Lincoln National (LNC) and MetLife (MET). Retail was mixed to higher. Shorts Nordstrom (JWN) and Foot Locker (FL) didn't do a damn thing. Old tech flat lined. Autos rallied small but could get hit on the after-the-close news. I covered much of my shorts in the belly of Monday's declines. I am a short seller on strength now. iShares Nasdaq Biotechnology ETF (IBB) was up $5. Allergan (AGN) rose $3 and there were good gains for value plays Celgene (CELG) and Gilead Sciences (GILD). Energy and media were mixed. Ag equipment was mixed. Caterpillar (CAT) was up a half a buck but Deere (DE) was down after a Morgan Stanley downgrade yesterday. (T)FANG returned to favor, led by Amazon (AMZN), Alphabet (GOOGL) and Netflix (NFLX), which caught an upgrade. Staples quieted down. In individual stocks, Twitter (TWTR) is making a move back toward some previous resistance (I added). My longs DuPont (DD) and Hartford Financial Services Group (HIG) showed little movement. Here are some value-added contributions on our site: 1. Jim "EL Capitan " Cramer gets toothy.  He also chimes on Tesla's (TSLA) accident.   Again, Tom Graff on bonds and Tim "Not Phil or Judy" Collins on bond spreads.  Eric Jackson on the impact of the Lions Gate (LGF) deal on Viacom (VIAB).  Rev Shark on correction risks.
By

David Katz

 | Jun 29, 2016 | 8:00 AM EDT

These names are now oversold and are sitting at attractive prices.

By

Bruce Kamich

 | Jun 22, 2016 | 3:03 PM EDT

A new low down at $80 might be just enough weakness to prompt further declines.

By

Bret Jensen

 | Jun 20, 2016 | 12:00 PM EDT

Large biotech stocks are still at their cheapest valuations since 2011.

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.